NSC |
Compound |
Enrichment |
Correlation |
NSC 746685 |
[(2-phenyl-1H-indol-3-yl)methylene]malononitrile |
0.0186200143729975 |
0.016865143 |
NSC 109825 |
Null |
0.0195202843390061 |
0.29839811 |
NSC 11668 |
N4,N6-bis(3-chlorophenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine |
0.0195202843390061 |
0.18342853 |
NSC 172599 |
7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl- |
0.0195202843390061 |
-0.037472149 |
NSC 302325 |
2,4-Pyrimidinediamine, 5-(4-chloro-3-nitrophenyl)-6-ethyl- |
0.0195202843390061 |
0.49352804 |
NSC 3091 |
Ammonium, [.alpha.-[p-(dimethylamino)phenyl]-.alpha.-[4-(dimethyliminio)-2,5-cyclohexadien-1-ylidene]-p-tolyl]ethyldimethyl-, bromide, chloride (8CI) |
0.0195202843390061 |
0.26402417 |
NSC 328186 |
3',4',5'-trimethoxy-3-hydroxy flavone |
0.0195202843390061 |
0.22879436 |
NSC 381866 |
BAFILOMYCIN DERIV. |
0.0195202843390061 |
0.18679199 |
NSC 606698 |
Rapamycin prodrug, Mono-(28)-N,N-dimethylglycinate-, methanesulfonic acid salt |
0.0195202843390061 |
0.14383012 |
NSC 633781 |
1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate |
0.0195202843390061 |
0.41491276 |